Calex Pharmaceuticals Private Limited - Due diligence report

A 360° intelligence report on Calex Pharmaceuticals Private Limited: trust score, financial health, credit view, compliance, directors, grow…

2003-06-06 Jabalpur, Madhya Pradesh Strike Off Unlisted
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Calex Pharmaceuticals Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
47/100
Trust Score
Caution Indicated

Calex Pharmaceuticals Private Limited is assessed as Caution Indicated with a Trust Score of 47/100. Calex Pharmaceuticals Private Limited is a private limited indian non-government company incorporated in 2003, operating in the Chemicals sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.

Report generated on 13 Oct 2026 from the latest processed filings. Calex Pharmaceuticals Private Limited snapshot & full profile →

Financial Health › Weak
Overall Assessment CautionWeakNeutralGoodStrong Neutral
Compliance › Weak

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreCaution Indicated
47/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
30/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
40/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
40/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 2 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 30/100 Caution Indicated
  • Company status is "Strike Off" - not Active.
  • Last balance sheet is for Mar 2017 - filings overdue.
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
AVINASH KUMAR SAXENA 01234567 Director 01/04/2018 6 yrs Approved
SHARAD KUMAR GUPTA 01234567 Director 01/04/2018 6 yrs Approved
MANISH NOUGRHIYA GUPTA 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • MANISH NOUGRHIYA GUPTA has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2017 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 40
Growth signals & trust indicators
Operating for 23+ years.
Distress signals & risk flags
Revenue declined year-on-year.
Statutory filings appear overdue.
Adverse company status: Strike Off.
Compliance score is weak (30/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence38/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 3 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment40/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view42/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 6 events
30 Sep 2017
Last AGM held
Annual general meeting
31 Mar 2017
Latest balance sheet
Filed with ROC
05 Jan 2008
Director appointed
AVINASH KUMAR SAXENA (Director)
06 Jun 2003
Incorporated
Registered with Roc Gwalior
Director appointed
SHARAD KUMAR GUPTA (Director)
Director appointed
MANISH NOUGRHIYA GUPTA (Director)
10

Key Observations

Auto-generated from the data above
Revenue declined 38% over the last 1 financial year(s).
3 active director(s) / partner(s); review board churn before relying on management continuity.
Promoters hold a dominant controlling stake as per the FY 2017 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Gosai E-Commerce Private Limited U74999MP2020PTC052772 Jabalpur, Madhya Pradesh
JABALPUR FOOD FACTORY LLP AAB-3477 Jabalpur, Madhya Pradesh
Intell Wave Marketing And Services Private Limited U52392MP1997PTC011862 Jabalpur, Madhya Pradesh
Land Lord Infrastructure Private Limited U45200MP2012PTC028807 Jabalpur, Madhya Pradesh
Easy Performance Marketing Private Limited U52599MP2011PTC026053 Jabalpur, Madhya Pradesh
Jagati Mining Company Private Limited U13100MP2013PTC030812 Jabalpur, Madhya Pradesh
SICKBAY HEALTHCARE LLP ABC-0655 Jabalpur, Madhya Pradesh
Pitambara Delights Private Limited U55209MP2022PTC059815 Jabalpur, Madhya Pradesh
Gta Infracon Limited U70101MP2012PLC027533 Jabalpur, Madhya Pradesh
Navdeep Agro Tech Private Limited U24233MP1996PTC010727 Jabalpur, Madhya Pradesh
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Calex Pharmaceuticals Private Limited before audits and certifications: compliance score 30/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Calex Pharmaceuticals Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 40/100, margin trends, ownership structure and peer set for Calex Pharmaceuticals Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 47/100, distress signals and MSME payment-delay disclosures - know whether Calex Pharmaceuticals Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Calex Pharmaceuticals Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Calex Pharmaceuticals Private Limited an active company?

Calex Pharmaceuticals Private Limited has MCA status “Strike Off” with a compliance score of 30/100 (Caution Indicated).

Is Calex Pharmaceuticals Private Limited financially healthy?

Calex Pharmaceuticals Private Limited has a Financial Health Score of 40/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Calex Pharmaceuticals Private Limited?

Its overall Trust Score is 47/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Calex Pharmaceuticals Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Calex Pharmaceuticals Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Calex Pharmaceuticals Private Limited up to date with its ROC filings?

Last balance sheet is for Mar 2017 - filings overdue. Overall compliance score: 30/100 (Caution Indicated).

Is it risky to lend to Calex Pharmaceuticals Private Limited?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.